Niagen Bioscience, Inc.
NAGENASDAQHealthcareBiotechnology

About Niagen Bioscience

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceuticalgrade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also offers the supply of phytochemical reference standards and other research and development services. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

Company Information

CEORobert Fried
Founded1999
Employees104
CountryUnited States
Fiscal YearJanuary - December

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Phone310 388 6706
Address
10900 Wilshire Blvd, Suite 600 Los Angeles, California 90024 United States

Corporate Identifiers

CIK0000851773
CUSIP171077407
ISINUS1710774076

Leadership Team & Key Executives

Robert N. Fried
Chief Executive Officer and Director
Frank Louis Jaksch Jr.
Co-Founder and Chairman
Ozan Pamir C.F.A.
Chief Financial Officer and Principal Accounting Officer
Carlos Lopez
Senior Vice President and General Counsel
James Lee
Controller
Dr. Andrew Shao Ph.D.
Senior Vice President of Global Regulatory and Scientific Affairs
Michiko Kelley
Chief Marketing Officer
Chu Yan
Managing Director of Asia Pacific
Kendall Knysch
Head of Media Relations and Partnerships
Wesley Yu
Vice President of Finance